The weekly litigation news digest is live. Subscribe now

Janssen Alzheimer Immunotherapy competitive analysis

Loading summary...

Explore Janssen Alzheimer Immunotherapy's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1

Latest PTAB cases involving Janssen Alzheimer Immunotherapy

Discover the latest PTAB cases involving Janssen Alzheimer Immunotherapy, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Janssen Alzheimer Immunotherapy with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JANSSEN ALZHEIMER IMMUNOTHERAPY - 1 - -
MATHYS & SQUIRE54 - - -